• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一名重症肌无力患儿经他克莫司治疗成功]

[A child with generalized myasthenia gravis successfully treated with tacrolimus].

作者信息

Goto Tamako, Mori Masato, Yamagata Takanori, Mizuguchi Masashi, Momoi Mariko Y

机构信息

Department of Pediatrics, Jichi University, Shimotsuke, Tochigi.

出版信息

No To Hattatsu. 2007 Jul;39(4):300-3.

PMID:17633089
Abstract

A 7-year-old girl was diagnosed with generalized myasthenia gravis and became steroid-dependent. Dose of prednisolone could not be reduced to < 2 mg/kg/day on alternate days, despite adverse effects. Thymectomy was avoided. Oral tacrolimus was initiated at 1.0 - 1.3 mg/kg/day. Ptosis and weakness of the lingual and pharyngeal muscles began to ameliorate 2 weeks later, and disappeared within 2 months. Serum titer of anti-acetylcholine receptor antibody also declined. During the subsequent two years, remission was maintained although prednisolone was reduced to half the original dose. No adverse effects of tacrolimus were noted. This case suggests the usefulness of tacrolimus in the treatment of childhood myasthenia gravis.

摘要

一名7岁女孩被诊断为全身型重症肌无力,且对类固醇产生依赖。尽管有不良反应,但泼尼松龙的剂量无法隔日减至<2mg/kg/天。避免了胸腺切除术。开始口服他克莫司,剂量为1.0 - 1.3mg/kg/天。2周后上睑下垂以及舌肌和咽肌无力开始改善,并在2个月内消失。抗乙酰胆碱受体抗体的血清滴度也下降。在随后的两年中,尽管泼尼松龙减至原剂量的一半,但仍维持缓解状态。未观察到他克莫司的不良反应。该病例提示他克莫司在儿童重症肌无力治疗中有用。

相似文献

1
[A child with generalized myasthenia gravis successfully treated with tacrolimus].[一名重症肌无力患儿经他克莫司治疗成功]
No To Hattatsu. 2007 Jul;39(4):300-3.
2
Successful treatment of a 2-year-old girl with intractable myasthenia gravis using tacrolimus.
Brain Dev. 2006 Sep;28(8):534-6. doi: 10.1016/j.braindev.2006.02.001. Epub 2006 Mar 29.
3
Benefits of FK 506 for refractory eye symptoms in a young child with ocular myasthenia gravis.FK506对一名患有眼肌型重症肌无力幼儿难治性眼部症状的疗效
Brain Dev. 2009 Sep;31(8):634-7. doi: 10.1016/j.braindev.2008.08.016. Epub 2008 Oct 9.
4
Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.他克莫司改善对泼尼松治疗抵抗的儿童重症肌无力的症状。
Pediatr Neurol. 2017 Dec;77:42-47. doi: 10.1016/j.pediatrneurol.2017.08.014. Epub 2017 Sep 5.
5
Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.低剂量他克莫司治疗两例重症肌无力合并侵袭性胸腺瘤患者,这两例患者在胸腺切除术后不久复发。
J Neurol Sci. 2005 Apr 15;231(1-2):85-8. doi: 10.1016/j.jns.2004.12.010. Epub 2005 Jan 25.
6
Effective treatment of a 13-year-old boy with steroid-dependent ocular myasthenia gravis using tacrolimus.使用他克莫司有效治疗一名13岁的类固醇依赖性眼肌型重症肌无力男孩。
Brain Dev. 2013 May;35(5):445-8. doi: 10.1016/j.braindev.2012.06.012. Epub 2012 Jul 26.
7
Long-term treatment of steroid-dependent myasthenia gravis patients with low-dose tacrolimus.低剂量他克莫司对激素依赖型重症肌无力患者的长期治疗
Intern Med. 2008;47(8):731-6. doi: 10.2169/internalmedicine.47.0513. Epub 2008 Apr 16.
8
Low-dose tacrolimus treatment in thymectomised and steroid-dependent myasthenia gravis.
Curr Med Res Opin. 2004 Aug;20(8):1269-73. doi: 10.1185/030079904125004385.
9
A 5-Year Follow-Up of Triple-Seronegative Myasthenia Gravis Successfully Treated with Tacrolimus Therapy.他克莫司治疗成功的三阴性重症肌无力5年随访
Neuropediatrics. 2018 Jun;49(3):200-203. doi: 10.1055/s-0037-1618591. Epub 2018 Jan 4.
10
Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis.重症肌无力患者低剂量他克莫司的 5 年随访。
J Neurol Sci. 2011 Jan 15;300(1-2):59-62. doi: 10.1016/j.jns.2010.09.033. Epub 2010 Oct 29.